英国癌症研究所的Andreas Schatzlein基于伦敦药学院结果，认为这是首次发现纳米微粒靶向肿瘤有如此好的选择性。
Cancer Research UK's Andreas Schatzlein, based at the School of Pharmacy in London, said it was the first time that nanoparticles had been shown to target tumors in such a selective way.
广州蛇毒研究所； 中山大学药学系；
He Quanhua; Xu Shibo and Peng Bo (Department of Pharmacy; Zhongshan University; Guangzhou 510275);
应用推荐